68 related articles for article (PubMed ID: 9329627)
1. Tenascin-C tissue concentration in inflammatory and neoplastic diseases of the colon mucosa.
Riedl S; Kadmon M; Tandara A; Hinz U; Möller P; Faissner A
Anticancer Res; 1997; 17(4B):3165-6. PubMed ID: 9329627
[TBL] [Abstract][Full Text] [Related]
2. Detection of tenascin-C isoforms in colorectal mucosa, ulcerative colitis, carcinomas and liver metastases.
Dueck M; Riedl S; Hinz U; Tandara A; Möller P; Herfarth C; Faissner A
Int J Cancer; 1999 Aug; 82(4):477-83. PubMed ID: 10404058
[TBL] [Abstract][Full Text] [Related]
3. Mucosal tenascin C content in inflammatory and neoplastic diseases of the large bowel.
Riedl S; Kadmon M; Tandara A; Hinz U; Möller P; Herfarth C; Faissner A
Dis Colon Rectum; 1998 Jan; 41(1):86-92. PubMed ID: 9510316
[TBL] [Abstract][Full Text] [Related]
4. Bactericidal/permeability-increasing protein in colonic mucosa in ulcerative colitis.
Haapamäki MM; Häggblom JO; Grönroos JM; Pekkala E; Alanen K; Nevalainen TJ
Hepatogastroenterology; 1999; 46(28):2273-7. PubMed ID: 10521980
[TBL] [Abstract][Full Text] [Related]
5. High c-myc protein expression in benign colorectal lesions correlates with the degree of dysplasia.
Pavelic ZP; Pavelic L; Kuvelkar R; Gapany SR
Anticancer Res; 1992; 12(1):171-5. PubMed ID: 1567165
[TBL] [Abstract][Full Text] [Related]
6. Altered content and distribution of tenascin in colitis, colon adenoma, and colorectal carcinoma.
Riedl SE; Faissner A; Schlag P; Von Herbay A; Koretz K; Möller P
Gastroenterology; 1992 Aug; 103(2):400-6. PubMed ID: 1378802
[TBL] [Abstract][Full Text] [Related]
7. Tenascin-W, a new marker of cancer stroma, is elevated in sera of colon and breast cancer patients.
Degen M; Brellier F; Schenk S; Driscoll R; Zaman K; Stupp R; Tornillo L; Terracciano L; Chiquet-Ehrismann R; Rüegg C; Seelentag W
Int J Cancer; 2008 Jun; 122(11):2454-61. PubMed ID: 18306355
[TBL] [Abstract][Full Text] [Related]
8. Low colonic glutathione detoxification capacity in patients at risk for colon cancer.
Grubben MJ; van den Braak CC; Nagengast FM; Peters WH
Eur J Clin Invest; 2006 Mar; 36(3):188-92. PubMed ID: 16506964
[TBL] [Abstract][Full Text] [Related]
9. [Tenascin: a simple tool in the diagnosis of collagenous colitis].
Ulrich S; Wagner U; Wegmann W
Schweiz Med Wochenschr; 1999 Sep; 129(38):1363-7. PubMed ID: 10536801
[TBL] [Abstract][Full Text] [Related]
10. Protein abundance alterations in matched sets of macroscopically normal colon mucosa and colorectal carcinoma.
Stulík J; Koupilova K; Osterreicher J; Knízek J; Macela A; Bures J; Jandík P; Langr F; Dedic K; Jungblut PR
Electrophoresis; 1999 Dec; 20(18):3638-46. PubMed ID: 10612291
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
12. The significance of Tenascin-C serum level as tumor marker in squamous cell carcinoma of the head and neck.
Pauli C; Stieber P; Schmitt UM; Andratschke M; Hoffmann K; Wollenberg B
Anticancer Res; 2002; 22(5):3093-7. PubMed ID: 12530049
[TBL] [Abstract][Full Text] [Related]
13. Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel disease.
Nishida Y; Murase K; Isomoto H; Furusu H; Mizuta Y; Riddell RH; Kohno S
Hepatogastroenterology; 2002; 49(45):678-82. PubMed ID: 12063968
[TBL] [Abstract][Full Text] [Related]
14. A high degree of aneuploidy, loss of p53 gene, and low soluble p53 protein serum levels are detected in ulcerative colitis patients.
Rosman-Urbach M; Niv Y; Birk Y; Smirnoff P; Zusman I; Morgenstern S; Schwartz B
Dis Colon Rectum; 2004 Mar; 47(3):304-13. PubMed ID: 14991492
[TBL] [Abstract][Full Text] [Related]
15. Substance P and vasoactive intestinal polypeptide but not calcitonin gene-related peptide concentrations are reduced in patients with moderate and severe ulcerative colitis.
Renzi D; Mantellini P; Calabrò A; Panerai C; Amorosi A; Paladini I; Salvadori G; Garcea MR; Surrenti C
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):62-70. PubMed ID: 9615269
[TBL] [Abstract][Full Text] [Related]
16. Altered cryptal expression of luminal potassium (BK) channels in ulcerative colitis.
Sandle GI; Perry MD; Mathialahan T; Linley JE; Robinson P; Hunter M; MacLennan KA
J Pathol; 2007 May; 212(1):66-73. PubMed ID: 17405186
[TBL] [Abstract][Full Text] [Related]
17. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
18. The analysis of S100A9 and S100A8 expression in matched sets of macroscopically normal colon mucosa and colorectal carcinoma: the S100A9 and S100A8 positive cells underlie and invade tumor mass.
Stulík J; Osterreicher J; Koupilová K; Knízek ; Macela A; Bures J; Jandík P; Langr F; Dedic K; Jungblut PR
Electrophoresis; 1999; 20(4-5):1047-54. PubMed ID: 10344284
[TBL] [Abstract][Full Text] [Related]
19. The distribution of collagen types I, III, and IV in normal and malignant colorectal mucosa.
Hilska M; Collan Y; Peltonen J; Gullichsen R; Paajanen H; Laato M
Eur J Surg; 1998 Jun; 164(6):457-64. PubMed ID: 9696447
[TBL] [Abstract][Full Text] [Related]
20. Two-dimensional electrophoretic study of normal colon mucosa and colorectal cancer.
Kovarova H; Stulík J; Hochstrasser DF; Bures J; Melichar B; Jandík P
Appl Theor Electrophor; 1994; 4(3):103-6. PubMed ID: 7612691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
